Lv11
28 积分 2026-04-30 加入
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus
53分钟前
求助中
1401 Effects of anifrolumab on renal disease in patients with systemic lupus erythematosus
59分钟前
求助中
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
13天前
已完结
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
26天前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
26天前
已完结
High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: a prospective MIDAS Consortium study
26天前
已完结
Autosomal dominant polycystic kidney disease: New insights into treatment
30天前
已完结
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis
1个月前
已完结
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
2个月前
已完结
皖公网安备34019202002308
